Tested Applications
| Positive WB detected in | A549 cells, human brain tissue, human stomach tissue | 
| Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0  | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 | 
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below | 
| WB | See 3 publications below | 
| IF | See 1 publications below | 
Product Information
55248-1-AP targets GPR35 in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human | 
| Cited Reactivity | human, mouse | 
| Host / Isotype | Rabbit / IgG | 
| Class | Polyclonal | 
| Type | Antibody | 
| Immunogen | 
                                             Peptide Predict reactive species | 
                                    
| Full Name | G protein-coupled receptor 35 | 
| Calculated Molecular Weight | 34 kDa | 
| Observed Molecular Weight | 34 kDa | 
| GenBank Accession Number | NM_005301 | 
| Gene Symbol | GPR35 | 
| Gene ID (NCBI) | 2859 | 
| RRID | AB_10836935 | 
| Conjugate | Unconjugated | 
| Form | Liquid | 
| Purification Method | Antigen affinity purification | 
| UNIPROT ID | Q9HC97 | 
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. | 
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. | 
Background Information
GPR35, also named the KYNA receptor, belongs to the G-protein coupled receptor 1 family. GPR35 acts as a receptor for kynurenic acid, an intermediate in the tryptophan metabolic pathway. The activity of GPR35 is mediated by G-proteins that elicit calcium mobilization and inositol phosphate production through G(qi/o) proteins (PMID:16754668). This antibody is specific to GPR35.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for GPR35 antibody 55248-1-AP | Download protocol | 
| WB protocol for GPR35 antibody 55248-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
Acta Pharm Sin B Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage.
  | ||
Eur J Pharmacol Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis | ||
Science Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists | ||
Microbiol Spectr Prognostic implications of the interaction between intratumoral microbiome and immune response in gastric cancer | 











